| Spagnoli LG et al. |
Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. |
1995 |
Atherosclerosis |
pmid:7605374
|
| Orlandi A et al. |
Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. |
2002 |
Atherosclerosis |
pmid:11755925
|
| Al-Majed AA |
Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats. |
2007 |
Basic Clin. Pharmacol. Toxicol. |
pmid:17309516
|
| Tassani V et al. |
Anaplerotic effect of propionyl carnitine in rat heart mitochondria. |
1994 |
Biochem. Biophys. Res. Commun. |
pmid:8135845
|
| Sherry AD et al. |
Propionate metabolism in the rat heart by 13C n.m.r. spectroscopy. |
1988 |
Biochem. J. |
pmid:3178775
|
| Brass EP and Stabler SP |
Carnitine metabolism in the vitamin B-12-deficient rat. |
1988 |
Biochem. J. |
pmid:3196310
|
| Brass EP et al. |
Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes. |
1986 |
Biochem. J. |
pmid:3790065
|
| Triggiani M et al. |
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. |
1999 |
Biochem. Pharmacol. |
pmid:10487538
|
| Brass EP et al. |
Effect of carnitine acetyltransferase inhibition on rat hepatocyte metabolism. |
1991 |
Biochim. Biophys. Acta |
pmid:1932127
|
| Arduini A et al. |
Effects of L-carnitine and its acetate and propionate esters on the molecular dynamics of human erythrocyte membrane. |
1993 |
Biochim. Biophys. Acta |
pmid:8383998
|
| Hokland BM and Bremer J |
Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney. |
1986 |
Biochim. Biophys. Acta |
pmid:3697382
|
| Vargiu R et al. |
Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters. |
2008 |
Biofactors |
pmid:19096109
|
| Vargiu R et al. |
Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle. |
2010 May-Jun |
Biofactors |
pmid:20533397
|
| Origlia N et al. |
Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity. |
2006 |
Biomed. Pharmacother. |
pmid:16472963
|
| Cavallini G et al. |
Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease. |
2002 |
BJU Int. |
pmid:12010235
|
| Pace S et al. |
Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption. |
2000 |
Br J Clin Pharmacol |
pmid:11069438
|
| Mingorance C et al. |
Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats. |
2009 |
Br. J. Nutr. |
pmid:19545458
|
| Elliott GR et al. |
The effect of acute feeding of carnitine, acetyl carnitine and propionyl carnitine on basal and A23187-stimulated eicosanoid release from rat carrageenan-elicited peritoneal macrophages. |
1990 |
Br. J. Nutr. |
pmid:2171633
|
| Barbieri M et al. |
Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties. |
1991 |
Br. J. Pharmacol. |
pmid:2043933
|
| Laviano A et al. |
Carnitine administration reduces cytokine levels, improves food intake, and ameliorates body composition in tumor-bearing rats. |
2011 |
Cancer Invest. |
pmid:22085273
|
| Huang Q et al. |
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. |
2013 |
Cancer Res. |
pmid:23824744
|
| Koh SG et al. |
Exercise intolerance during post-MI heart failure in rats: prevention with supplemental dietary propionyl-L-carnitine. |
2003 |
Cardiovasc Drugs Ther |
pmid:12843682
|
| Milio G et al. |
Pharmacological treatment of patients with chronic critical limb ischemia: L-propionyl-carnitine enhances the short-term effects of PGE-1. |
2009 |
Cardiovasc Drugs Ther |
pmid:19548076
|
| Lango R et al. |
Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients. |
2005 |
Cardiovasc Drugs Ther |
pmid:16187006
|
| De Marchi S et al. |
Propionyl-L-carnitine improves endothelial function, microcirculation and pain management in critical limb ischemia. |
2012 |
Cardiovasc Drugs Ther |
pmid:22936457
|
| Vanella A et al. |
L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. |
2000 |
Cell Biol. Toxicol. |
pmid:10917565
|
| Zhang Y et al. |
Prenatal diagnosis of methylmalonic aciduria by analysis of organic acids and total homocysteine in amniotic fluid. |
2008 |
Chin. Med. J. |
pmid:18298912
|
| Schönekess BO et al. |
Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. |
1995 |
Circ. Res. |
pmid:7554119
|
| Brevetti G et al. |
Muscle carnitine deficiency in patients with severe peripheral vascular disease. |
1991 |
Circulation |
pmid:1914091
|
| Montisci R et al. |
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. |
2007 |
Clin Ther |
pmid:17379056
|
| Kushnir MM et al. |
Serum acylcarnitines and vitamin B12 deficiency. |
2002 |
Clin. Chem. |
pmid:12089192
|
| Chace DH et al. |
Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. |
2001 |
Clin. Chem. |
pmid:11673377
|
| la Marca G et al. |
Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. |
2007 |
Clin. Chem. |
pmid:17510301
|
| Chapman KA et al. |
Increased C3-carnitine in a healthy premature infant. |
2008 |
Clin. Chem. |
pmid:18957557
|
| Wikoff WR et al. |
Metabolomics identifies perturbations in human disorders of propionate metabolism. |
2007 |
Clin. Chem. |
pmid:17951291
|
| De Jesús VR et al. |
Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. |
2010 |
Clin. Chim. Acta |
pmid:20122909
|
| Libert R et al. |
Identification of undescribed medium-chain acylcarnitines present in urine of patients with propionic and methylmalonic acidemias. |
2000 |
Clin. Chim. Acta |
pmid:10767396
|
| Di Donato S et al. |
Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. |
1984 |
Clin. Chim. Acta |
pmid:6723070
|
| Aleisa AM et al. |
Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues. |
2007 |
Clin. Exp. Pharmacol. Physiol. |
pmid:17973863
|
| Al-Majed AA et al. |
Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16895547
|
| Sethi R et al. |
Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction. |
2004 |
Coron. Artery Dis. |
pmid:15201623
|
| Gentile V et al. |
Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes. |
2004 |
Curr Med Res Opin |
pmid:15383186
|
| Gentile V et al. |
Effect of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes. |
2009 |
Curr Med Res Opin |
pmid:19624286
|
| Malaguarnera M |
Carnitine derivatives: clinical usefulness. |
2012 |
Curr. Opin. Gastroenterol. |
pmid:22333562
|
| Felix C et al. |
Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart. |
2001 |
Diabetes Res. Clin. Pract. |
pmid:11378209
|
| Santo SS et al. |
Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD. |
2006 |
Diabetes Res. Clin. Pract. |
pmid:16446007
|
| Mancinelli A et al. |
Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver. |
2000 |
Drug Metab. Dispos. |
pmid:11095575
|
| Signorelli SS et al. |
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis. |
2006 |
Drugs Aging |
pmid:16608381
|
| Wiseman LR and Brogden RN |
Propionyl-L-carnitine. |
1998 |
Drugs Aging |
pmid:9534023
|
| Broderick TL et al. |
Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart. |
2004 |
Drugs R D |
pmid:15230624
|
